Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients

November 15, 2023 updated by: Gokce Yagmur Gunes Gencer, Akdeniz University
The aim of this study is to investigate the Turkish adaptation of the Comprehensive Coordination Scale and its validity and reliability in Parkinson's patients.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

A Turkish version of the Comprehensive Coordination Scale will be made. Then, Comprehensive Coordination Scale, 9-Hole Peg Test, Timed Up and Go Test, Berg Balance Scale, Functional Reaching Test and Modified Hoehn and Yahr Scale will be applied to patients with Parkinson's, respectively. In order to determine the reliability of the scale, only the "Comprehensive Coordination Scale" will be video recorded during the first evaluation and inter-rater reliability will be performed by another physiotherapist. For test-retest reliability, patients will be evaluated seven days later by the first physiotherapist who made the evaluation by watching the video again.

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Antalya, Turkey, 07070
        • Recruiting
        • Gökçe Yağmur Güneş Gencer
        • Contact:
      • Antalya, Turkey
        • Recruiting
        • Ozel Termessos Hastanesi
        • Contact:
          • Nazan Ş Erdem, MD
          • Phone Number: +90242 212 18 18

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Parkinson's patients

Description

Inclusion Criteria:

  • Diagnosed with Parkinson's,
  • Mini mental test score over 24,
  • Those who have not experienced any serious neurological or orthopedic problems in the last 6 months,
  • İndividuals who agreed to participate in the study

Exclusion Criteria:

  • Mini mental test score <24,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comprehensive Coordination Scale
Time Frame: Baseline (First assessment)
The Comprehensive Coordination Scale (CCS) is a measure of coordination of multiple body segments at both motor performance (endpoint movement) and quality of movement (joint rotations and interjoint coordination) levels based on observational kinematics.
Baseline (First assessment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
9 Hole Peg Test
Time Frame: Baseline (First assessment)
The Nine-Hole Peg Test (9-HPT) is a standardized, quantitative assessment used to measure finger dexterity.
Baseline (First assessment)
Timed Up and Go Test (TUG)
Time Frame: Baseline (First assessment)
The Timed Up and Go Test (TUG) assesses mobility, balance, walking ability, and fall risk in older adults.
Baseline (First assessment)
Berg Balance Test
Time Frame: Baseline (First assessment)
The Berg Balance Scale (BBS) is a 14-item objective measure that assesses static balance and fall risk in adults.
Baseline (First assessment)
Functional Reach Test
Time Frame: Baseline (First assessment)
The Functional Reach Test assesses a patient's stability by measuring the maximum distance an individual can reach forward while standing in a fixed position.
Baseline (First assessment)
Modified Hoehn and Yahr Scale
Time Frame: Baseline (First assessment)
The Hoehn and Yahr scale is used to describe the symptom progression of Parkinson disease
Baseline (First assessment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gökçe Yağmur Güneş Gencer, Assist.Prof., Akdeniz University
  • Study Chair: Lütfiye Akkurt, Assist.Prof., Kütahya Health Sciences University
  • Study Chair: Hayri Aktaş, MSc, Akdeniz University
  • Study Chair: Nazan Ş Erdem, MD, Ozel Termessos Hastanesi

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 5, 2023

Primary Completion (Estimated)

January 5, 2024

Study Completion (Estimated)

January 30, 2024

Study Registration Dates

First Submitted

November 15, 2023

First Submitted That Met QC Criteria

November 15, 2023

First Posted (Estimated)

November 20, 2023

Study Record Updates

Last Update Posted (Estimated)

November 20, 2023

Last Update Submitted That Met QC Criteria

November 15, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Validity and Reliability

Subscribe